ENDRA Life Sciences Inc.
NDRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,229 | $2,834 | $4,889 | $9,462 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $2,645 | $1,285 |
| Other Curr. Assets | $204 | $199 | $993 | $1,348 |
| Total Curr. Assets | $3,434 | $3,033 | $8,527 | $12,094 |
| Property Plant & Equip (Net) | $647 | $466 | $741 | $775 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $371 | $3,255 | $6 | $6 |
| Total NC Assets | $1,019 | $3,721 | $747 | $781 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,452 | $6,754 | $9,274 | $12,875 |
| Liabilities | – | – | – | – |
| Payables | $270 | $360 | $614 | $791 |
| Short-Term Debt | $97 | $202 | $181 | $249 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $239 | $340 | $909 | $503 |
| Total Curr. Liab. | $605 | $903 | $1,704 | $1,544 |
| LT Debt | $487 | $192 | $366 | $547 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $799 | $0 | $0 | $0 |
| Total NC Liab. | $1,287 | $192 | $366 | $547 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $584 | $366 | $518 | $650 |
| Total Liabilities | $1,892 | $1,095 | $2,070 | $2,090 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $1 | $0 | $0 |
| Retained Earnings | -$103,438 | -$91,930 | -$81,870 | -$68,691 |
| AOCI | $0 | $5 | $6 | $14 |
| Other Equity | $105,998 | $97,583 | $89,068 | $79,461 |
| Total Equity | $2,560 | $5,659 | $7,205 | $10,784 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,452 | $6,754 | $9,274 | $12,875 |
| Net Debt | -$2,645 | -$2,440 | -$4,342 | -$8,665 |